上海源力生物技术有限公司 (Unitris Biopharma Co. Ltd.) 是一家由中、美医药企业家、科学家创立的中美合资企业, 致力于研究开发有自主知识产权的一类新药。公司位于上海浦东新区张江药谷。 源力立足国内, 面向全球医药市场。
源力以人才为本，注重选拔人才、培养人才，为科研人员创造一流的科研、工作环境。公司配备有现代药物研发所需的先进仪器、设备及研发平台。公司在药物化学、药物优化、ADME、药理学、临床前评价、早期临床试验及成果转让方面有丰富的研发经验及独到的技术优势。源力运用较先进的药物研发理论和管理模式, 综合国内、外新药研发的技术及产业优势, 创新、求实，通过研发新药为人类的健康事业做贡献。
Unitris Biopharma Co. Ltd is a research-based biopharmaceutical company that discovers and develops innovative medicines for unmet medical needs. Our primary areas of focus include oncology, cardiovascular and diabetics. Located in the Zhangjiang pharmaceutical valley at Shanghai, Unitris Biopharma was established by leading entrepreneurs and scientists from both the USA and China to face the challenges of the global pharmaceutical market.
We attract and develop the best talent for our business with a state-of-the-art working environment and a talent-based management system. Our laboratories are equipped with modern instruments and platforms for cutting-edge drug discovery research. We have established a broad range of capabilities for drug discovery and exploratory development including target validation, medicinal chemistry, lead optimization, ADME, pharmacology, preclinical and exploratory clinical development. By taking advantages of the research resources, R&D experiences and the pool of talent from the USA and China, we strive to create a pipeline of novel drugs to address urgent unmet medical needs.